Cationic phosphorodiamidate morpholino oligomers efficiently prevent growth of Escherichia coli in vitro and in vivo. (Q43250119)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19884121%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

title

Cationic phosphorodiamidate morpholino oligomers efficiently prevent growth of Escherichia coli in vitro and in vivo (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19884121%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19884121%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

author name string

Brett L Mellbye

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19884121%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Dwight D Weller

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19884121%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Jed N Hassinger

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19884121%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Matthew D Reeves

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19884121%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Candace E Lovejoy

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19884121%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Bruce L Geller

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19884121%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

language of work or name

English

0 references

publication date

1 January 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19884121%20AND%20SRC:MED&resulttype=core&format=json

Journal of Antimicrobial Chemotherapy

11 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19884121%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

volume

65

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19884121%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19884121%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

page(s)

98-106

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19884121%20AND%20SRC:MED&resulttype=core&format=json

Antibacterial resistance worldwide: causes, challenges and responses

11 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP392

The threat of antibiotic resistance in Gram-negative pathogenic bacteria: beta-lactams in peril!

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP392

Antibiotic resistance as a global threat: evidence from China, Kuwait and the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP392

Clinical and economic impact of common multidrug-resistant gram-negative bacilli

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP392

Resistance in gram-negative bacteria: enterobacteriaceae

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP392

Extensively drug-resistant tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP392

XDR Tuberculosis — Implications for Global Public Health

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP392

Vancomycin resistance in gram-positive cocci

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP392

Current trends in rapid diagnostics for methicillin-resistant Staphylococcus aureus and glycopeptide-resistant enterococcus species

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP392

MRSA--the tip of the iceberg

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP392

Outcome of infections due to pandrug-resistant (PDR) Gram-negative bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP392

The epidemiological profile of infections with multidrug-resistant Pseudomonas aeruginosa and Acinetobacter species

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP392

Tackling antibiotic resistance: a dose of common antisense?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP392

Inhibition of Gene Expression inEscherichia coliby Antisense Phosphorodiamidate Morpholino Oligomers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP392

Inhibition of gene expression and growth by antisense peptide nucleic acids in a multiresistant beta-lactamase-producing Klebsiella pneumoniae strain

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP392

Inhibition of Staphylococcus aureus gene expression and growth using antisense peptide nucleic acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP392

Gene-specific effects of antisense phosphorodiamidate morpholino oligomer-peptide conjugates on Escherichia coli and Salmonella enterica serovar typhimurium in pure culture and in tissue culture.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP392

Antisense phosphorodiamidate morpholino oligomer inhibits viability of Escherichia coli in pure culture and in mouse peritonitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP392

Antisense peptide-phosphorodiamidate morpholino oligomer conjugate: dose-response in mice infected with Escherichia coli.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP392

Variations in amino acid composition of antisense peptide-phosphorodiamidate morpholino oligomer affect potency against Escherichia coli in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP392

Antisense phosphorodiamidate morpholino oligomer length and target position effects on gene-specific inhibition in Escherichia coli.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP392

Bactericidal antisense effects of peptide-PNA conjugates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP392

Mutants of Escherichia coli permeable to actinomycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP392

Antisense inhibition of gene expression in bacteria by PNA targeted to mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP392

Antisense PNA effects in Escherichia coli are limited by the outer-membrane LPS layer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP392

Cationic host defense (antimicrobial) peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP392

Mechanisms of antimicrobial peptide action and resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP392

Pharmacokinetics, biodistribution, stability and toxicity of a cell-penetrating peptide-morpholino oligomer conjugate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP392

Treatment of AG129 mice with antisense morpholino oligomers increases survival time following challenge with dengue 2 virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP392

21 January 2018

Identifiers

DOI

10.1093/JAC/DKP392

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19884121%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

1 reference